12,281 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Acquired by Natixis Advisors LLC

Key Points

• Natixis Advisors LLC purchased a new stake in Surgery Partners, Inc. for approximately $292,000 by acquiring 12,281 shares.
• Analysts remain optimistic about Surgery Partners, with three ratings for "hold" and six for "buy," and an average target price of $33.00.
• For the most recent quarter, Surgery Partners reported $826.20 million in revenue, exceeding analyst estimates, with earnings per share of $0.17.

Natixis Advisors LLC acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,281 shares of the company's stock, valued at approximately $292,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale bought a new position in Surgery Partners in the 1st quarter worth approximately $65,000. State of Wyoming lifted its stake in Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after purchasing an additional 1,943 shares during the period. Point72 Asia Singapore Pte. Ltd. grew its stake in shares of Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after purchasing an additional 465 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Surgery Partners by 7,902.7% in the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock valued at $211,000 after purchasing an additional 8,772 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Surgery Partners by 279.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after acquiring an additional 7,925 shares in the last quarter.

Surgery Partners Stock Performance

Shares of NASDAQ:SGRY traded up $0.30 during midday trading on Friday, hitting $22.80. The company had a trading volume of 1,074,741 shares, compared to its average volume of 1,416,623. Surgery Partners, Inc. has a 12-month low of $18.87 and a 12-month high of $33.97. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. The company has a market cap of $2.92 billion, a price-to-earnings ratio of -15.94 and a beta of 1.82. The company has a fifty day moving average of $22.13 and a two-hundred day moving average of $23.01.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $826.20 million during the quarter, compared to the consensus estimate of $816.96 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.21 EPS. On average, equities research analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Bank of America started coverage on Surgery Partners in a research note on Monday, July 28th. They issued a "buy" rating and a $28.00 price target for the company. Barclays dropped their price target on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Finally, Benchmark reissued a "buy" rating and set a $35.00 price objective on shares of Surgery Partners in a report on Monday, April 21st. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $33.00.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.